Multiplexed multicolor antiviral assay amenable for high-throughput research
© 2024. The Author(s)..
To curb viral epidemics and pandemics, antiviral drugs are needed with activity against entire genera or families of viruses. Here, we develop a cell-based multiplex antiviral assay for high-throughput screening against multiple viruses at once, as demonstrated by using three distantly related orthoflaviviruses: dengue, Japanese encephalitis and yellow fever virus. Each virus is tagged with a distinct fluorescent protein, enabling individual monitoring in cell culture through high-content imaging. Specific antisera and small-molecule inhibitors are employed to validate that multiplexing approach yields comparable inhibition profiles to single-virus infection assays. To facilitate downstream analysis, a kernel is developed to deconvolute and reduce the multidimensional quantitative data to three cartesian coordinates. The methodology is applicable to viruses from different families as exemplified by co-infections with chikungunya, parainfluenza and Bunyamwera viruses. The multiplex approach is expected to facilitate the discovery of broader-spectrum antivirals, as shown in a pilot screen of approximately 1200 drug-like small-molecules.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
Nature communications - 15(2024), 1 vom: 02. Jan., Seite 42 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Li, Li-Hsin [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 05.01.2024 Date Revised 05.01.2024 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41467-023-44339-z |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM36658720X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM36658720X | ||
003 | DE-627 | ||
005 | 20240108142248.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240108s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41467-023-44339-z |2 doi | |
028 | 5 | 2 | |a pubmed24n1249.xml |
035 | |a (DE-627)NLM36658720X | ||
035 | |a (NLM)38168091 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Li, Li-Hsin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Multiplexed multicolor antiviral assay amenable for high-throughput research |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 05.01.2024 | ||
500 | |a Date Revised 05.01.2024 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2024. The Author(s). | ||
520 | |a To curb viral epidemics and pandemics, antiviral drugs are needed with activity against entire genera or families of viruses. Here, we develop a cell-based multiplex antiviral assay for high-throughput screening against multiple viruses at once, as demonstrated by using three distantly related orthoflaviviruses: dengue, Japanese encephalitis and yellow fever virus. Each virus is tagged with a distinct fluorescent protein, enabling individual monitoring in cell culture through high-content imaging. Specific antisera and small-molecule inhibitors are employed to validate that multiplexing approach yields comparable inhibition profiles to single-virus infection assays. To facilitate downstream analysis, a kernel is developed to deconvolute and reduce the multidimensional quantitative data to three cartesian coordinates. The methodology is applicable to viruses from different families as exemplified by co-infections with chikungunya, parainfluenza and Bunyamwera viruses. The multiplex approach is expected to facilitate the discovery of broader-spectrum antivirals, as shown in a pilot screen of approximately 1200 drug-like small-molecules | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Antiviral Agents |2 NLM | |
700 | 1 | |a Chiu, Winston |e verfasserin |4 aut | |
700 | 1 | |a Huang, Yun-An |e verfasserin |4 aut | |
700 | 1 | |a Rasulova, Madina |e verfasserin |4 aut | |
700 | 1 | |a Vercruysse, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Thibaut, Hendrik Jan |e verfasserin |4 aut | |
700 | 1 | |a Ter Horst, Sebastiaan |e verfasserin |4 aut | |
700 | 1 | |a Rocha-Pereira, Joana |e verfasserin |4 aut | |
700 | 1 | |a Vanhoof, Greet |e verfasserin |4 aut | |
700 | 1 | |a Borrenberghs, Doortje |e verfasserin |4 aut | |
700 | 1 | |a Goethals, Olivia |e verfasserin |4 aut | |
700 | 1 | |a Kaptein, Suzanne J F |e verfasserin |4 aut | |
700 | 1 | |a Leyssen, Pieter |e verfasserin |4 aut | |
700 | 1 | |a Neyts, Johan |e verfasserin |4 aut | |
700 | 1 | |a Dallmeier, Kai |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nature communications |d 2010 |g 15(2024), 1 vom: 02. Jan., Seite 42 |w (DE-627)NLM199274525 |x 2041-1723 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2024 |g number:1 |g day:02 |g month:01 |g pages:42 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41467-023-44339-z |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2024 |e 1 |b 02 |c 01 |h 42 |